Get to know Drive’s ScriptBio AI

We recently sat down with the five techbio companies accepted into the Fall 2026 Drive cohort to learn more about their science, their “ah-ha” moments, and how Drive is changing the trajectory of their business. Next up, it’s ScriptBio AI, a techbio company using generative AI to design compact gene editors, one target at a time. We spoke with founder and CEO, Patrick Ovando-Roche.

1. What problem are you obsessed with solving—and why does it matter right now? 

My father had Parkinson’s, and my mother has Alzheimer’s. Watching their diseases progress despite treatment is why I built ScriptBio AI. I’m obsessed with finding what drives these diseases so we can work toward treatments that change their course before the damage is irreparable.

We’re building a causal AI…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks